The Effectiveness and Barriers of Medicine Review in Managing Elderly Polypharmacy
DOI:
https://doi.org/10.61173/8t7v1339Keywords:
Polypharmacy, medication review, elderly, effectiveness, barriersAbstract
Polypharmacy is increasingly common among elderly population. While the use of multiple medications may be clinical unavoidable due to multiple health conditions, however, non-essential and inappropriate polypharmacy can increase the risk of poorer health outcomes such as medication-related complications. The following paper evaluates the effectiveness of medication review intervention in addressing polypharmacy in older population, especially on the reduction of the number of medications used, adverse events and health expenditure. The barriers that affect the effectiveness of medication review service. The findings demonstrate that by identifying the inappropriate medication therapies and provide improved medication plans, medication review service can help to reduce the number of medications that was used by the patient, medication-related side effects and expenditure on healthcare. However, the effectiveness of medication review is challenged by both patient’s health literacy and systemic barriers included time constrains and limited healthcare resources. Both factors could further compromise the effect of medication review in addressing polypharmacy. Consequently, it is clinical and practical essential to ensure that the use of multiple medications among elderly population are appropriate and clinical necessary, as this can help to improve the health outcome of the elderly patients and a more efficient allocation of the healthcare resources.
References
[1] World Health Organization. (2019). Medication safety in polypharmacy: Technical report. World Health Organization. https://www.who.int/docs/default-source/patient-safety/whouhc-sds-2019-11-eng.pdf
[2] Kim, S., Lee, H., Park, J., et al. (2024). Global and regional prevalence of polypharmacy and related factors, 1997–2022: An umbrella review. Archives of Gerontology and Geriatrics, 124, Article 105465.
[3] Australian Institute of Health and Welfare. (2024). OECD health care quality and outcomes indicators, Australia 2022- 23. Retrieved December 27, 2025, from https://www.aihw. gov.au/reports/international-comparisons/oecd-health-careindicators-2022-23/contents/prescribing-in-primary-care
[4] Gillespie, R., Mullan, J., & Harrison, L. (2019). Attitudes towards deprescribing and the influence of health literacy among older Australians. Primary Health Care Research & Development, 20, Article e78.
[5] Persaud, N., Workentin, A., Rizvi, A., et al. (2025). Interventions to Address Potentially Inappropriate Prescribing for Older Primary Care Patients: A Systematic Review and Meta-Analysis. JAMA Network Open, 8(6), e2517965.
[6] Papastergiou, J., Luen, M., Tencaliuc, S., et al. (2019). Medication management issues identified during home medication reviews for ambulatory community pharmacy patients. Canadian Pharmacists Journal, 152(5), 334–342.
[7] Kornholt, J., Feizi, S. T., Hansen, A. S., et al. (2022). Effects of a comprehensive medication review intervention on health‐ related quality of life and other clinical outcomes in geriatric outpatients with polypharmacy: A pragmatic randomized clinical trial. British Journal of Clinical Pharmacology, 88(7), 3360– 3369.
[8] Aljeaidi, M. S., Haaksma, M. L., & Tan, E. C. K. (2022). Polypharmacy and trajectories of health-related quality of life in older adults: an Australian cohort study. Quality of Life Research, 31(9), 2663–2671.
[9] Chae, J., Cho, H. J., Yoon, S.-H., & Kim, D.-S. (2024). The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: a nationwide large cohort study. Frontiers in Dean&Francis Qiongbing Huang Pharmacology, 15, 1382990.
[10] Ming, Y., Zecevic, A. A., Hunter, S. W., et al. (2021). Medication Review in Preventing Older Adults’ Fall-Related Injury: a Systematic Review & Meta-Analysis. Canadian Geriatrics Journal CGJ, 24(3), 237–250.
[11] Malet‐Larrea, A., Goyenechea, E., García‐Cárdenas, V., et al. (2016). The impact of a medication review with follow‐up service on hospital admissions in aged polypharmacy patients. British Journal of Clinical Pharmacology, 82(3), 831–838.
[12] Pan, S., Li, S., Shi, Y., et al. (2025). Polypharmacy and healthcare expenditures among older adults in the United States: a propensity score-matched study. BMC Geriatrics.
[13] Jungo, K. T., Salari, P., Meier, R., et al. (2024). Costeffectiveness of a medication review intervention for general practitioners and their multimorbid older patients with polypharmacy. Socio-Economic Planning Sciences, 92, Article 101837.
[14] Abuzour, A. S., Wilson, S. A., Woodall, A. A., et al. (2024). A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study. PloS One, 19(8), e0299770.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
